TRAF2 and breast carcinoma: Whilst these findings indicate that TRAF6 is an important regulator of breast cancer tumorigenesis and metastasis, accumulating evidence from studies in advanced breast cancer patients suggests that the expression of TRAF2 and 4 is associated with poor survival rates.